Acotec Scientific Holdings (STU:7W3) Other Stockholders Equity: €17.10 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:7W3 Acotec Scientific Holdings Ltd STU:7W3
76 GF Score
Price €0.68
GF Value €1.58
! 4 Warning Signs
View Full Analysis

What is Acotec Scientific Holdings Other Stockholders Equity?

Acotec Scientific Holdings STU:7W3 76 Other Stockholders Equity is €17.10 Mil as of Dec. 2025. GuruFocus rates STU:7W3 with a GF Score™ of 76/100 and a GF Value™ of €1.58. The stock has 4 warning signs investors should review.

Acotec Scientific Holdings's Other Stockholders Equity for the quarter that ended in Dec. 2025 was €17.10 Mil.

Acotec Scientific Holdings's quarterly Other Stockholders Equity declined from Dec. 2024 (€14.65 Mil) to Jun. 2025 (€14.10 Mil) but then increased from Jun. 2025 (€14.10 Mil) to Dec. 2025 (€17.10 Mil).

Acotec Scientific Holdings's annual Other Stockholders Equity increased from Dec. 2023 (€14.21 Mil) to Dec. 2024 (€14.65 Mil) and increased from Dec. 2024 (€14.65 Mil) to Dec. 2025 (€17.10 Mil).

Acotec Scientific Holdings Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Acotec Scientific Holdings's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acotec Scientific Holdings Other Stockholders Equity Chart

Acotec Scientific Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 14.72 14.17 14.21 14.65 17.10

Acotec Scientific Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.22 14.65 14.10 17.10 178.76
STU:7W3
76GF Score
Acotec Scientific Holdings Ltd STU:7W3
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acotec Scientific Holdings Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €17.10 Mil mean?
Acotec Scientific Holdings (STU:7W3) has a Other Stockholders Equity of €17.10 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Acotec Scientific Holdings and its competitors.
Is Acotec Scientific Holdings' Other Stockholders Equity too high?
Acotec Scientific Holdings' current Other Stockholders Equity is €17.10 Mil. Overall, Acotec Scientific Holdings has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Acotec Scientific Holdings' Other Stockholders Equity compare to ABT and SYK?
Acotec Scientific Holdings' Other Stockholders Equity of €17.10 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Acotec Scientific Holdings and its competitors. Acotec Scientific Holdings's current Other Stockholders Equity is €17.10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acotec Scientific Holdings stock overvalued right now?
Acotec Scientific Holdings (STU:7W3) has a current Other Stockholders Equity of €17.10 Mil. The stock's GF Value™ is €1.58, compared to a current price of €0.68 — trading 57% below its estimated fair value. The current Other Stockholders Equity is €17.10 Mil. Acotec Scientific Holdings' overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Acotec Scientific Holdings (STU:7W3), the current Other Stockholders Equity is €17.10 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acotec Scientific Holdings (STU:7W3) Overvalued in 2026?

Based on GuruFocus' analysis, Acotec Scientific Holdings stock appears to be undervalued. The current stock price of €0.68 is trading 57% below its estimated GF Value™ of €1.58.

Key valuation signals for STU:7W3:

  • Other Stockholders Equity: €17.10 Mil
  • GF Value™: €1.58 vs. price of €0.68 (57% below fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the STU:7W3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Acotec Scientific Holdings Business Description

Other Exchanges 06669:Hong Kong
Address 16 North Hongda Road, 4-5th Floor, Building No. 1, Beijing Economic-Technological Development Area, Beijing, CHN
Acotec Scientific Holdings Ltd is a medical technology company, focusing on the research and development, and application of technology platforms in the field of vascular interventional treatment. Its product portfolio comprises Semi-compliant PTCA balloon (YAN), Coronary CTO Recanalization Balloon (RT-Zero), Coronary CTO Antegrade Micro-Catheter (Vericor-14), Coronary High-Pressure Balloon (YIYAN), Coronary CTO Retrograde Micro-Catheter (Vericor-RS), Cardiac Valve Balloon Dilation Catheter (RunFlow), etc., and also has various other products in its development pipeline. Geographically, the company generates a majority of its revenue from Mainland China, and the rest from other regions. The firm generates the majority of its revenue from sales to Domestic distributors.
76GF Score

Get the complete analysis for STU:7W3

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.68
Price
€1.58
GF Value